Literature DB >> 10089353

Structures of the catalytic site mutants D99A and H48Q and the calcium-loop mutant D49E of phospholipase A2.

K Sekar1, R Biswas, Y Li, M Tsai, M Sundaralingam.   

Abstract

Crystal structures of the active-site mutants D99A and H48Q and the calcium-loop mutant D49E of bovine phospholipase A2 have been determined at around 1.9 A resolution. The D99A mutant is isomorphous to the orthorhombic recombinant enzyme, space group P212121. The H48Q and the calcium-loop mutant D49E are isomorphous to the trigonal recombinant enzyme, space group P3121. The two active-site mutants show no major structural perturbations. The structural water is absent in D99A and, therefore, the hydrogen-bonding scheme is changed. In H48Q, the catalytic water is present and hydrogen bonded to Gln48 N, but the second water found in native His48 is absent. In the calcium-loop mutant D49E, the two water molecules forming the pentagonal bipyramid around calcium are absent and only one O atom of the Glu49 carboxylate group is coordinated to calcium, resulting in only four ligands.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089353     DOI: 10.1107/s0907444998013699

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  6 in total

1.  Atomic resolution (0.97 A) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2.

Authors:  K Sekar; V Rajakannan; D Gayathri; D Velmurugan; M-J Poi; M Dauter; Z Dauter; M-D Tsai
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2004-09-25

2.  Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.

Authors:  Richard J Ward; Lucimara Chioato; Arthur H C de Oliveira; Roberto Ruller; Juliana M Sá
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

Authors:  Morgane Rouault; Lachlan D Rash; Pierre Escoubas; Eric Boilard; James Bollinger; Bruno Lomonte; Thomas Maurin; Carole Guillaume; Stéphane Canaan; Christiane Deregnaucourt; Joseph Schrével; Alain Doglio; José María Gutiérrez; Michel Lazdunski; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2006-05-09       Impact factor: 3.162

4.  Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.

Authors:  Jae-Ouk Kim; Bimal K Chakrabarti; Anuradha Guha-Niyogi; Mark K Louder; John R Mascola; Lakshmanan Ganesh; Gary J Nabel
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

5.  Structural effects of covalent inhibition of phospholipase A2 suggest allosteric coupling between membrane binding and catalytic sites.

Authors:  Suren A Tatulian
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

6.  Possible roles of S···O and S···N interactions in the functions and evolution of phospholipase A2.

Authors:  Michio Iwaoka; Noriyoshi Isozumi
Journal:  Biophysics (Nagoya-shi)       Date:  2006-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.